US 9133129
Bicyclic compound
granted A61KA61K31/343A61K31/416
Quick answer
US patent 9133129 (Bicyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/343, A61K31/416, A61K31/4184, A61K31/422